oral bpc-157 supplement BPC-157 Pure Oral Spray, .85
Description
The regulatory landscape is evolving: in February 2026, HHS announced that approximately 14 previously restricted peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, and Sermorelin are expected to return to Category 1 compounding status
The stomach lining is normally protected by a mucosal layer that prevents the stomach from, essentially, digesting itself
Correct reconstitution avoids losses
Entering a target dose of 4,000mcg shows a draw volume of 0.4mL, or 40 units on a U-100 syringe
